Skip to content

Fiax Transferrin Test Kit

by Intl. Diagnostic Technology 510(k)

Active United States

510(k) K842071

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK842071 Date11 Jul 1984ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 5 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DDI
Device Class
Class II
Regulation
21 CFR Part 866.5880
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Fiax Transferrin Test Kit is an immunological test system classified as a transferrin assay device. It employs fluorescent immunochemical techniques to quantify transferrin, a serum protein involved in iron transport, within serum, plasma, and other body fluids. This diagnostic tool aids in assessing conditions related to iron metabolism or protein deficiencies. The kit includes essential reagents such as FITC-labeled antigen, antiserum, and control materials to ensure accurate measurement.

This device is supplied as a diagnostic reagent kit for in vitro use in clinical laboratories. It is intended for single-use and requires proper storage under controlled conditions to maintain reagent integrity. The kit is regulated under FDA 510(k) clearance (K842071) and falls under the Immunology specialty category, adhering to Class II medical device standards. No additional sterility or MRI safety considerations are specified, and compliance with regulatory requirements ensures its suitability for diagnostic applications in clinical settings.

Other devices from Intl. Diagnostic Technology

See all devices from Intl. Diagnostic Technology →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Fiax Transferrin Test Kit used for?

    The Fiax Transferrin Test Kit is designed to measure transferrin levels in serum, plasma, and other body fluids using fluorescent immunochemical techniques. Transferrin is a key serum protein responsible for iron transport, so this assay helps clinicians evaluate conditions related to iron metabolism disorders or protein deficiencies, such as iron-deficiency anemia or hypoproteinemia.

  • How is the Fiax Transferrin Test Kit supplied, and is it single-use?

    The kit is supplied as a diagnostic reagent kit intended for in vitro use in clinical laboratories. It contains all necessary components, including FITC-labeled antigen, antiserum, and control materials. Due to its composition and regulatory classification, the kit is intended for single-use only to ensure accuracy and prevent cross-contamination.

  • Does the kit require special storage conditions?

    Yes, the kit must be stored under controlled conditions to preserve reagent integrity. While specific storage temperatures or humidity requirements aren’t detailed in the data, typical immunoassay kits like this generally require refrigeration (2–8°C) and protection from light. Always refer to the included instructions for precise storage guidelines to maintain test validity.

  • Is sterility or MRI safety relevant for this device?

    The provided data does not specify any sterility requirements or MRI safety considerations for the Fiax Transferrin Test Kit. It is classified as a Class II diagnostic device under FDA 510(k) clearance (K842071) and is intended for laboratory use, where standard aseptic practices apply. No additional precautions beyond typical immunoassay handling are mentioned.

  • What regulatory pathway does this kit follow?

    The Fiax Transferrin Test Kit follows the FDA 510(k) clearance pathway, specifically under the Immunology specialty category (reviewed by the Immunology/Microbiology Advisory Committee). It was granted Substantially Equivalent (SESE) status in 1984 (clearance K842071) and adheres to Class II medical device standards. This classification ensures it meets stringent performance and safety criteria for in vitro diagnostic use.